Amgen Inc. is experiencing a notable rise in its stock price, reflecting positive investor sentiment.
Amgen Inc. (NASDAQ:AMGN) is rising today, gaining 2.28% to close at CA$416.72. This uptick comes amid a favorable earnings outlook and positive revisions in analyst expectations.
Advertisement
Amgen Inc
AMGN.US
AMGN.US
Amgen Inc
WealthAwesomeMarket cap
$223.32B
P/E
25.0x
Div. yield
2.43%
Div. / share
$9.80
52W high
$447.03
52W low
$280.23
1W change
+0.04%
Beta
0.41
Analyst Price Targets
Based on 34 analysts covering AMGN · as of Oct 9, 2026
Wall Street analysts forecast AMGN stock price to fall 3.9% over the next 12 months.
Consensus
Hold3.35 / 5.00
Avg. Target
C$391.46
-3.9% Upside
Previously C$390.94 on Oct 5, 2026
Current Price
C$407.44
Last close
Analyst Breakdown (34 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AMGN's historical volatility
30-Day Vol
40.1%
Annualized
90-Day Vol
32.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$487.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$432.43 | C$376.50 – C$496.67 |
| 60 trading days | C$458.95 | C$377.31 – C$558.25 |
| 90 trading days | C$487.10 | C$383.21 – C$619.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may find Amgen's current performance encouraging, particularly with its strong revenue growth and positive analyst sentiment ahead of the upcoming earnings season.
Amgen's Stock Gains 2.28%
The stock's rise today reflects growing investor confidence, supported by favorable earnings revisions and positive market sentiment.
Bull case
Amgen's recent earnings report showed a 9.5% year-over-year revenue increase, surpassing analysts' expectations. The company also received an A+ EPS revision grade, indicating strong analyst confidence in its future performance.
Bear case
While the stock is performing well, investors should remain cautious about potential market volatility and external pressures, such as competition in the biotech sector and regulatory challenges.
Strong Earnings Performance
Advertisement
Amgen's recent earnings report highlighted a 9.5% increase in revenue year-over-year, reaching $10.05 billion. This performance not only exceeded analysts' expectations but also set a positive tone for the upcoming earnings season, as the company continues to show resilience in a competitive market.
Analyst Upgrades Boost Confidence
Analysts have shown increased confidence in Amgen's future performance, awarding the company an A+ EPS revision grade. This rating reflects a favorable shift in earnings expectations, contributing to the stock's rise as investors anticipate continued growth.
Market Sentiment and Future Outlook
The overall market sentiment towards biotechnology stocks remains cautiously optimistic, with Amgen positioned well to capitalize on upcoming trends in the healthcare sector. However, investors should stay alert to potential risks, including regulatory challenges and market fluctuations that could impact performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
